CDC Backs Boosters for High-Risk Kids Aged 5-11, Shorter Time Between Shots
[ad_1] By Robin Foster HealthDay Reporter TUESDAY, Jan. 4, 2022 (HealthDay News) The U.S. Centers for Disease Control and Prevention on Tuesday backed the emergency use approval of Pfizer’s booster shot for high-risk kids between the ages of 5 and 11, along with shortening the time period between a second dose and a booster shot […]
Read More